ICH GCP R3 is now in English & EU languages. Book Now
  • Preclinical & Laboratory Foundations
  • Phase I – First-in-Human Trials
  • Phase II & III – Efficacy & Pivotal Trials
  • Clinical Trials Foundation PathNew
  • Regulatory Submission & Approval
Preclinical & Laboratory Foundations - courses at £229
  • Good Laboratory Practice (GLP)
  • 21 CFR Part 58 — Good Laboratory Practice (GLP) for Nonclinical Laboratories
  • OSHA Laboratory Safety Training
  • Laboratory Management Systems ISO/IEC 17025:2017
  • Computer System Validation - Validation, Data Integrity & Compliance (GAMP 5 & Annex 11)
  • Qualification Validation Training
  • Cleaning Validation
  • ISO 9001:2015 - Quality Management System for Pharmaceuticals

About

The Foundations of Medical Writing Learning Path is designed to provide aspiring and early-career medical writers, pharmacovigilance associates, and regulatory professionals with the essential knowledge and skills required to produce accurate, compliant, and well-structured documents across the pharmaceutical and life sciences industry. Covering the scope of medical writing in pharma, clinical trial and GCP foundations, good documentation practices, pharmacovigilance system fundamentals, literature monitoring, and PBRER preparation, this programme builds a structured bridge between regulatory knowledge and practical writing competency.

Participants will develop an understanding of the regulatory environment in which medical writing operates, the documentation and data integrity standards that govern all regulated outputs, the pharmacovigilance framework that informs safety writing, and the practical skills required to contribute to periodic safety reports and literature-based surveillance activities — providing the competency platform needed to progress into a professional medical writing career.

How this differs from advanced medical writing programmes

The Foundations of Medical Writing Learning Path is designed as a structured entry point for professionals new to medical writing or transitioning from adjacent roles such as clinical research, pharmacy, nursing, or laboratory science. It focuses on building regulatory awareness, GCP and GVP literacy, documentation discipline, and introductory safety writing skills.

More advanced medical writing programmes build on these foundations to cover Clinical Study Reports (CSRs), clinical overviews, investigator brochures, regulatory submission dossiers, and complex benefit-risk communication. This learning path is the recommended starting point before progressing to specialist clinical, regulatory, or pharmacovigilance medical writing programmes.


Who should enrol:

  • Junior Medical Writers entering the pharmaceutical or CRO industry
  • Pharmacovigilance Associates and Drug Safety professionals developing writing skills
  • Regulatory Affairs Associates seeking a structured regulatory writing foundation
  • Medical Information Associates involved in safety and product documentation
  • Healthcare professionals (pharmacists, nurses, doctors) transitioning into pharmaceutical medical writing
  • Life sciences graduates pursuing careers in medical writing, PV, or regulatory affairs
  • Clinical research professionals seeking to expand into writing and regulatory functions

Courses Included

Introduction to Medical Writing

An overview of the medical writing function in the pharmaceutical industry — document types, regulatory submission context, writing standards, and the role of the medical writer across the drug development lifecycle

duration3 hoursCPD points2 points
More Info
Fundamentals of Clinical Trials

Foundational clinical trial concepts and ICH GCP E6 (R3) principles — trial phases, key stakeholder roles, protocol structure, ethics requirements, and GCP documentation standards relevant to medical writers

duration3 hoursCPD points3 points
More Info
Good Documentation Practices and Data Integrity

ALCOA+ principles, audit trail requirements, source data standards, and documentation practices — the quality foundation underpinning all regulated medical writing outputs

duration3 hoursCPD points3 points
More Info
Introduction to Good Pharmacovigilance Practice

Foundations of pharmacovigilance — GVP modules, MAH obligations, adverse event reporting, and the regulatory framework within which PV medical writing takes place

duration3 hoursCPD points2 points
More Info
Screening and Management of Literature for Pharmacovigilance Activities

Systematic literature monitoring as a GVP Module VI obligation — search strategies, triage of identified cases, and the medical writer's role in ongoing safety surveillance

duration2 hoursCPD points3 points
More Info
Medical Writing of Periodic Benefit-Risk Evaluation Report (PBRER)

PBRER structure, benefit-risk evaluation methodology, integrated summary of safety, and ICH E2C(R2) alignment — core advanced writing competency for PV and regulatory medical writers

duration2 hoursCPD points3 points
More Info

Our Certified Customers

novartis
NHS
takeda
roche
baxter

Learner Rating & Reviews

4.7
Average Rating
536 global ratings
87.0%
5.0%
3.0%
3.0%
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...

Frequently Asked Questions

  • Junior Medical Writers entering the pharmaceutical or CRO industry
  • Pharmacovigilance Associates and Drug Safety professionals developing writing skills
  • Regulatory Affairs Associates seeking a structured regulatory writing foundation
  • Medical Information Associates involved in safety and product documentation
  • Healthcare professionals (pharmacists, nurses, doctors) transitioning into pharmaceutical medical writing
  • Life sciences graduates pursuing careers in medical writing, PV, or regulatory affairs
  • Clinical research professionals seeking to expand into writing and regulatory functions

Upon completion of this learning path, participants will be able to describe the scope and document types of pharmaceutical medical writing, apply ICH GCP E6 (R3) principles in a writing context, produce documentation in line with ALCOA+ data integrity standards, understand the pharmacovigilance framework and GVP obligations relevant to safety writing, conduct and manage literature screening for PV purposes, and contribute to the preparation of Periodic Benefit-Risk Evaluation Reports (PBRERs) in alignment with ICH E2C(R2) — equipping them to begin a professional career in medical writing, pharmacovigilance, or regulatory affairs.